微信直播

Arthur Sagalowsky:减瘤性肾切除术对转移性肾细胞癌仍然重要

Published at: 2015年第1卷第S1期

高凤平
关键词:

编者按:5月6日至10日,2016年美国泌尿协会年会(American Urological Association Annual Meeting) 在美国圣迭戈(San Diego)成功举办。会议上,我们有幸邀请到来自德克萨斯大学西南医学中心(University of Texas Southwestern Medical Center)的泌尿科教授Arthur Sagalowsky与我们共同分享膀胱癌方面的相关研究以及转移性肾细胞癌中减瘤性肾切除术的重要性。

 

采访中,Prof. Sagalowsky与我们探讨了与过去十年相比,现今膀胱癌在美国的发病率及变化,同时,Prof. Sagalowsky也与我们分享了其在膀胱癌转化研究方面的一些进展。

针对会议中关于泌尿研究现存争议的其中一个话题--“减瘤性肾切除术对转移性肾细胞癌仍然重要”(Cytoreductive Nephrectomy is Still Important for Advanced/Metastatic Renal Cell Cancer),Prof. Sagalowsky结合多年经验,与我们详细道出了他独特看法。

作为有着多年经验的泌尿科医生,Prof. Sagalowsky最后更与我们分享了他早年的从医故事及其日常对学生的教导重心。

访谈视频

图一: 与Prof. Sagalowsky的合影

 

采访问题

  1. 此前会议上,您主持了“Bladder Cancer: Epidemiology & Evaluation”这一环节,同时我们知道您也是膀胱癌治疗及转化研究方面的专家,您能否与我们分享一下现今美国膀胱癌的发病率?与过去十年相比有何改变?

  2. 您能否与我们分享一下您在膀胱癌转化研究方面的一些进展?

  3. 针对会议上的“Cytoreductive Nephrectomy is Still Important for Advanced/Metastatic Renal Cell Cancer”一话题,您的个人看法是什么?

  4. 作为泌尿科的著名专家,您能否与我们分享一下您作为泌尿医生的一些早期有趣或是鼓动人心的故事?

  5. 您对年轻外科医生有什么建议吗?

 

专家介绍

Arthur Sagalowsky, M.D., is a Professor of Urology at UT Southwestern Medical Center, with joint appointments in the Departments of Urology and Surgery. He is the holder of the Paul C. Peters Chair in Urology in Memory of Rumsey and Louis Strickland.

Prof. Sagalowsky specializes in all aspects of urological malignancies and related urinary tract reconstruction. He has unique surgical experience with: radical cystectomy and continent urinary diversion with orthotopic neobladders and cutaneous reservoirs; open nerve-sparing radical prostatectomy, and, in select cases, nerve-sparing cystoprostatectomy for patients with prostate cancer or bladder cancer; complex partial nephrectomy for patients with large localized kidney tumors where preservation of renal function by nephron sparing surgery is important; radical nephrectomy for large kidney tumor debulking; and resection of  tumors with tumor thrombus into the vena cava (and even into the heart); debulking retroperitoneal lymph node dissection for testis cancer.

His research interests involve translational studies on bladder cancer and kidney cancer involving clinical diagnosis and treatment, and translational studies on molecular pathways as predictors of disease behavior and risk for recurrence, progression, response to treatment and disease-related mortality. He has published and spoken widely on these topics and has extensive experience in clinical trials.

Prof. Sagalowsky is a member of the American Association for Cancer Research, American College of Surgeons, American Society of Transplant Surgeons, American Urological Association, the Society of Urologic Oncology, and the American Association of Genitourinary Surgeons. He has been honored by Texas Monthly as a Super Doctor, and he is listed in America’s Top Doctors for Cancer.

 

采访编辑:高凤平,科学编辑,AME出版社

视频编辑:麦雪芳,视频编辑,AME出版社

doi:10.3978/kysj.2014.1.1907

comments powered by Disqus

附件